Wakeupcall

Buy Titan, Bombay Dyeing

Titan has decided to increase prices of its watches, which is likely to positively impact both its topline as well as profits. The stock can see some movement based on this news.

Buy Tata Motors, sell Glenmark

Tata Motors has surprised analysts by posting strong numbers for September.

Sell Reliance Capital; buy GVK Power, Bata

After closing of market hours news flashed that CBI will look into Anil Ambani's role in the 2G scam. Perception of repercussion of the inquiry will see selling pressure in all ADAG group stocks. Reliance Capital being the flaship can see the brunt of the bear attack.

Buy Pipavav, sell Reliance Power

News of Sterling Hotels being bought by investor Rakesh Junjhunwala and RK Damani, who have invested a little over Rs 80 crore for a 14 percent stake, is likely to see buying at the counter in opening trades.

Buy Cairn; sell Arvind, Allahabad Bank

ONGC has finally given the no objection certificate for the deal between Cairn and Vedanta. Delay in the deal had not only affected investor sentiment in Cairn, but was also affecting it operationally.

DLF to rise higher; GMR Infra to sell 30 pct stake to Petronas

Though DLF has moved up over the last two days, there is room for more. GMR Infrastructure said on Monday that it will be selling 30 percent stake in its unit GMR Energy (Singapore) Pte to Petronas.

ABB on a slide; Andhra Bank, Divi's Lab consolidate

ABB has been on a downward slide since its management said that they were witnessing margin pressure due to a slowdown in orders.

Tripping worries for DLF, BPCL may face crisis too

Introducing a real estate regulator to monitor its functioning is likely to impact the shares of DLF. Depreciating rupee may lead to crisis for shares of BPCL.

High hopes for Mercator Lines, REC likely to tumble

Mercator Lines is likely to see a new high after its announcement of acquiring 50 percent stake in Indonesian coal mine. While, a break below the support level for REC may bring its fall.

Subex likely to fall, Lupin set to make new high

Subex's no plans for stake sale may prove to be a bad move for its stocks. While, Lupin's announcement of US receiving US FDA will move it to a new high.